1-(3,4-dihydroxy-2-nitri-phenyl)-3-phenyl-propan-1-one

• 分子结构分类: 有机化合物 - 苯丙烷和聚酮 - 直链 1,3-二芳基丙烷
• 英文名称: 1-(3,4-dihydroxy-2-nitri-phenyl)-3-phenyl-propan-1-one
• 英文别名: 1-(3,4-dihydroxy-2-nitro-phenyl)-3-phenyl-propan-1-one；1-(3,4-Dihydroxy-2-nitrophenyl)-3-phenylpropan-1-one
• 化学式: C₁₅H₁₃NO₅
• 分子量: 287.272
• InChiKey: BEMQRBWIIUEHRF-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  3.2
• 重原子数：
  21
• 可旋转键数：
  4
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.13
• 拓扑面积：
  103
• 氢给体数：
  2
• 氢受体数：
  5

反应信息

• 作为产物：
  描述：

  1-(4-hydroxy-3-methoxyphenyl)-3-phenylpropan-1-one 在 吡啶 、 4-二甲氨基吡啶 、 sodium hydroxide 、 三氯化铝 、 乙酸酐 、 copper(II) nitrate 作用下， 以 甲醇 、 二氯甲烷 、 1,2-二氯乙烷 为溶剂， 反应 3.0h， 生成 1-(3,4-dihydroxy-2-nitri-phenyl)-3-phenyl-propan-1-one
  参考文献：
  名称：

  Synthesis and Biological Evaluation of a Novel Series of “Ortho-Nitrated” Inhibitors of Catechol-O-methyltransferase

  摘要：

  Novel regioisomeric "ortho-nitrated" catechols related to the catechol-O-methyltransferase (COMT) inhibitors BIA 3-202 3 and BIA 3-335 4 were synthesized and biologically evaluated. Changing the position of the nitro group from the "classical" meta- to the ortho-position relative to the side-chain substituent of the nitrocatechol pharmacophore exerted profound effects on selectivity and duration of COMT inhibition. Alkylaryl compounds 7a-d possessed shorter duration of action than their regioisomers, but 7b displayed reversed selectivity over 3 at 3 and 6 h, exhibiting preferential central inhibition. In the amino-substituted series, ortho-nitrated regioisomer 14k was less peripherally selective than 4 and short-acting, whereas decahydroquinoline 14g displayed an unprecedented combination of long-acting and selective peripheral inhibition. 7b could provide a useful tool to probe the pharmacological utility of short-acting, centrally selective COMT inhibitors in the treatment of depression in Parkinsonian patients, and 14g represents a promising candidate for clinical evaluation as an adjunct to L-Dopa therapy.

  DOI：

  10.1021/jm0580454

文献信息

• Substituted nitrated catechols, their use in the treatment of some central and peripheral nervous system disorders and pharmaceutical compositions containing them
  申请人：——

  公开号：US20020037931A1

  公开（公告）日：2002-03-28

  New compounds of formula I are described: 1 The compounds have potentially valuable pharmaceutical properties in the treatment of some central and peripheral nervous system disorders.

  新的化合物I的公式被描述如下： 这些化合物在治疗一些中枢和外周神经系统疾病中具有潜在的有价值的药理特性。
• [EN] SUBSTITUTED NITRATED CATECHOLS, THEIR USE IN THE TREATMENT OF SOME CENTRAL AND PERIPHERAL NERVOUS SYSTEM DISORDERS AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM<br/>[FR] CATECHINES NITREES SUBSTITUEES, LEUR UTILISATION DANS LE TRAITEMENT D'AFFECTIONS DU SYSTEME NERVEUX CENTRAL ET PERIPHERIQUE ET COMPOSITIONS PHARMACEUTIQUES LES CONTENANT
  申请人：PORTELA & CA SA

  公开号：WO2001098250A1

  公开（公告）日：2001-12-27

  New compounds of formula (I) are described. The compounds have potentially valuable pharmaceutical properties in the treatment of some central and peripheral nervous system disorders.
• Synthesis and Biological Evaluation of a Novel Series of “Ortho-Nitrated” Inhibitors of Catechol-<i>O</i>-methyltransferase
  作者：David A. Learmonth、Maria João Bonifácio、Patrício Soares-da-Silva

  DOI：10.1021/jm0580454

  日期：2005.12.1

  Novel regioisomeric "ortho-nitrated" catechols related to the catechol-O-methyltransferase (COMT) inhibitors BIA 3-202 3 and BIA 3-335 4 were synthesized and biologically evaluated. Changing the position of the nitro group from the "classical" meta- to the ortho-position relative to the side-chain substituent of the nitrocatechol pharmacophore exerted profound effects on selectivity and duration of COMT inhibition. Alkylaryl compounds 7a-d possessed shorter duration of action than their regioisomers, but 7b displayed reversed selectivity over 3 at 3 and 6 h, exhibiting preferential central inhibition. In the amino-substituted series, ortho-nitrated regioisomer 14k was less peripherally selective than 4 and short-acting, whereas decahydroquinoline 14g displayed an unprecedented combination of long-acting and selective peripheral inhibition. 7b could provide a useful tool to probe the pharmacological utility of short-acting, centrally selective COMT inhibitors in the treatment of depression in Parkinsonian patients, and 14g represents a promising candidate for clinical evaluation as an adjunct to L-Dopa therapy.